This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357
Clinical trial NCT03279978 · COMPLETED
Trial details
- NCT number
- NCT03279978
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-09
- Primary completion
- 2018-08-24
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.